Latest stories on TCRX
TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss
Yahoo Top58 · neutralearnings
TScan Therapeutics Expands Authorized Shares After Stockholder Vote
TipRanks50 · neutralgeneral
TCRX news roundup. 2 stories in the past week, 3 over 30 days. Average 30-day sentiment is 56.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.